Overview

Anecortave Acetate in Patients With Open-angle Glaucoma

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, efficacy, and duration of effect of a single administration of Anecortave Acetate Depot for treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma.
Phase:
Phase 2
Details
Lead Sponsor:
Alcon Research
Treatments:
Anecortave
Hydrocortisone